NASPAG celebrate the release of Opill. The first daily over the counter oral contraceptive available without a prescription—now shipping to retail pharmacies. See the press release below:
NASPAG was thrilled to participate in FDA testimony and advocate for access and accessibility to over-the-counter contraception further reducing barriers to contraception.
Statement to FDA on Over the Counter OCPs (2022)
NASPAG has endorsed ACOG’s practice advisory on the use of over-the-counter contraception. See the practice advisory below: